NDI Medical

NDI Medical, established in 2002 and based in Cleveland, Ohio, operates as a medical device incubator specializing in neurostimulation technologies. The company is dedicated to developing high-growth enterprises that aim to address significant unmet health needs. NDI Medical's team comprises experienced entrepreneurs, scientists, and physician advisors, along with experts in clinical and regulatory affairs, product development, quality assurance, and finance. By focusing on innovative neuro-device technologies, NDI Medical seeks to advance the field of medical devices and improve therapeutic outcomes for patients.

Les Vinney

Managing Director

4 past transactions

Checkpoint Surgical

Series C in 2015
Checkpoint Surgical Inc., established in 2009 and headquartered in Cleveland, Ohio, specializes in manufacturing neuro devices for surgeons. Their primary products are CHECKPOINT 9094 and CHECKPOINT 9394, both designed to locate, identify, and evaluate motor nerve tissue and muscle function during complex surgical procedures. These devices cater to various applications such as head and neck surgeries, hand and extremities procedures, targeted muscle re-innervation, orthopedic oncology and trauma, and plastic reconstruction. The company sells its products through a network of distributors in the United States, aiming to enhance patient outcomes by providing surgeons with precise nerve stimulation and monitoring equipment.

SPR Therapeutics

Series A in 2013
SPR Therapeutics, LLC is a medical device company focused on developing and commercializing interventional pain management therapies. The company specializes in peripheral nerve stimulation (PNS) products, including its flagship Smartpatch system, which provides short-term pain relief following surgeries and for various types of pain such as neuropathic and musculoskeletal pain. Smartpatch is designed for minimally invasive use, allowing for up to 30 days of electrical stimulation to alleviate pain. Additionally, the company offers the Micropulse system for long-term therapy through an implantable PNS solution. SPR Therapeutics aims to provide a non-narcotic alternative to opioids and invasive procedures, emphasizing safety, effectiveness, and affordability in pain management. Founded in 2009 and headquartered in Cleveland, Ohio, the company also has facilities in the Carolinas and Minneapolis.

Deep Brain Innovations

Seed Round in 2012
Deep Brain Innovations, LLC is a medical device company based in Cleveland, Ohio, founded in 2012. The company specializes in developing deep brain stimulation (DBS) systems aimed at treating the symptoms of Parkinson's disease. Its innovative technology optimizes the delivery of DBS therapy by targeting specific areas of the brain, which significantly reduces power consumption compared to conventional systems. This efficiency not only enhances the effectiveness of the treatment but also lowers the risks and costs associated with frequent surgical replacements of larger devices. Deep Brain Innovations focuses on improving patient outcomes while ensuring that the therapy remains accessible and sustainable for those affected by Parkinson's disease.

Checkpoint Surgical

Series B in 2012
Checkpoint Surgical Inc., established in 2009 and headquartered in Cleveland, Ohio, specializes in manufacturing neuro devices for surgeons. Their primary products are CHECKPOINT 9094 and CHECKPOINT 9394, both designed to locate, identify, and evaluate motor nerve tissue and muscle function during complex surgical procedures. These devices cater to various applications such as head and neck surgeries, hand and extremities procedures, targeted muscle re-innervation, orthopedic oncology and trauma, and plastic reconstruction. The company sells its products through a network of distributors in the United States, aiming to enhance patient outcomes by providing surgeons with precise nerve stimulation and monitoring equipment.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.